MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
< b > Condition < /b > : Middle East Respiratory Syndrome Coronavirus (MERS-CoV) < br/ > < b > Interventions < /b > : Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b; Drug: Placebo < br/ > < b > Sponsor < /b > : King Abdullah International Medical Research Center < br/ > < b > Not yet recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Betaseron | Coronavirus | Kaletra | MERS | Middle East Health | Norvir | Research | Respiratory Medicine